Industry News

Gore Receives FDA Approval for Endovascular Treatment of In-Stent Restenosis with the GORE� VIABAHN� Endoprosthesis
Merck Gets FDA Approval of Keytruda
Auxilium Pharma rejects Endo's takeover offer
Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership
Auxilium Pharma rejects Endo's takeover offer
Lundbeck Introduces NORTHERA (droxidopa) Capsules in the U.S. for Symptomatic Neurogenic Orthostatic Hypotension
ACADIA Pharmaceuticals Secures FDA Breakthrough Therapy Designation for NUPLAZID for Parkinson's Disease Psychosis
Ipsen Secures FDA Priority Review for Somatuline in Treatment of GEP- NETs in U.S.
Taxes and subsidies could encourage healthier diet and lower healthcare costs Tufts University, Health Sciences Campus
FDA Approves the Use of a Needle-Free Injection Device to Administer the Influenza Vaccine
Soligenix Awarded NIAID Contract Valued up to $24.7 Million for the Development of Heat Stable RiVax Vaccine
Soligenix Awarded NIAID Contract Valued up to $24.7 Million for the Development of Heat Stable RiVax� Vaccine
PCI Announces Acquisition Of Biotec PCI significantly expands Global Clinical Services business through Biotec acquisition
FDA OKs faster-acting label for ED drug Stendra
U.S. House of Representatives Passes Paulsen Legislation to Repeal Medical Device Tax
Minerva Neurosciences Announces Completion of FDA Review of Investigational New Drug Application for MIN-202 and Plans for First U.S.-Based Clinical Trial Bioavailability Study in U.S. for Investigational Therapy in Development for Treatment of Insomnia t
Baxter Gets FDA Approval for RIXUBIS [Coagulation Factor IX (Recombinant)] for Treatment of Children with Hemophilia B
FDA Warns Against Non-approved Dermal Filler
FDA Approves the Use of a Needle-Free Injection Device to Administer the Influenza Vaccine
AlloSource Signs Space Act Agreement With NASA And Jet Propulsion Laboratory Technology used in NASA Mars missions will provide insights into microbial testing related to tissue processing
EYLEA (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by year end
Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease
Nektar says FDA clears constipation drug Movantik
Walgreens Boots Alliance Files Form S-4 Registration Statement and Preliminary Proxy Statement/Prospectus Related to Walgreens Strategic Transaction with Alliance Boots
FDA Warns Against Non-approved Dermal Filler